Irene Strassl

10PUBLICATIONS
53CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Cardiovascular medicine and haematology not elsewhere classifiedRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 26, 2026
Real-world outcomes of ide-cel and cilta-cel in relapsed/refractory multiple myeloma: A nationwide, retrospective analysis in Austria.

|Jun 12, 2026
Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.

|Dec 30, 2025
Rapid Hematological and Molecular Response to Pegylated Interferon in WHO-Defined Pre-Fibrotic Myelofibrosis.

Sigrid Machherndl-Spandl, Marcel Kiehberger, Veronika Sygulla

|Apr 26, 2025
Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Prolymphocytic Leukemia.

Christina Groiss, Stefanie Kreissl, Irene Strassl

|Oct 16, 2024
Improved Outcomes in Myelofibrosis after Allogeneic Stem-Cell Transplantation in the Era of Ruxolitinib Pretreatment and Intensified Conditioning Regimen-Single-Center Analysis.

Sigrid Machherndl-Spandl, Sarah Hannouf, Alexander Nikoloudis

|Dec 23, 2023
Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options-A Single-Center Experience.

Irene Strassl, Alexander Nikoloudis, Sigrid Machherndl-Spandl

Pageof 2

Frequent Collaborators

7 joint publications

Johannes Clausen

6 joint publications

Veronika Buxhofer-Ausch

2 joint publications

Otto Zach

2 joint publications

Gerald Webersinke